No Picture
News

Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2018 and Recent Corporate Progress

– Heron Raises Full-Year 2018 CINV Franchise Net Product Sales Guidance to $70 Million to $72 Million –

SAN DIEGO, Nov. 7, 2018 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the… […]

No Picture
News

Viking Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update

Conference call scheduled for 4:30 p.m. ET today- Announced Positive Top-Line Results from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol (LDL-C)- Presented Positive Results from Phase 2 … […]

No Picture
News

BioMed Realty Announces First Major Tenant At Gateway Of Pacific, The Latest Expansion Of Life Science, Technology And Healthcare Relationships In Its Bay Area Portfolio

AbbVie is latest in series of market activity bringing BioMed Realty to Over 1.2 Million Square Feet of Bay Area Leasing in 2018

SAN FRANCISCO, Nov. 7, 2018 /PRNewswire/ — BioMed Realty, the leading provider of real estate solutions to the life scie… […]

No Picture
News

Evofem Biosciences Reports Third Quarter 2018 Financial Results and Provides Corporate Update

Management to Host Conference Call at 11:00 a.m. EST

SAN DIEGO, Nov. 7, 2018 /PRNewswire/ — Evofem Biosciences, Inc., (NASDAQ: EVFM) (“Evofem” or the “Company”), today reported financial results for the three- and nine- month periods ended September… […]